title: A rapid and systematic review of the clinical effectiveness and cost-effectiveness of gemcitabine for the treatment of pancreatic cancer.
authors.affiliation: School of Health and Related Research, University of Sheffield, UK.
authors.forename: S
authors.initials: S
authors.lastname: Ward
authors.forename: E
authors.initials: E
authors.lastname: Morris
authors.forename: N
authors.initials: N
authors.lastname: Bansback
authors.forename: N
authors.initials: N
authors.lastname: Calvert
authors.forename: A
authors.initials: A
authors.lastname: Crellin
authors.forename: D
authors.initials: D
authors.lastname: Forman
authors.forename: M
authors.initials: M
authors.lastname: Larvin
authors.forename: D
authors.initials: D
authors.lastname: Radstone
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D010190:Pancreatic Neoplasms / Q000188:drug therapy*; D011788:Quality of Life; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D005472:Fluorouracil; D000093542:Gemcitabine